Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria

Heinz Gisslinger(Medical University of Vienna), J. Thiele, Georg Jeryczynski(Medical University of Vienna), Christoph Kornauth(Munich Leukemia Laboratory (Germany)), A-I Schiefer(Medical University of Vienna), Veronika Buxhofer‐Ausch(Johannes Kepler University of Linz), Ingrid Simonitsch‐Klupp(Medical University of Vienna), Martin Schalling(Karolinska University Hospital), Albert Wölfler(Medical University of Graz), Bettina Gisslinger(Medical University of Vienna), Christine Beham‐Schmid(Medical University of Graz), Sonja Burgstaller(Klinikum Wels-Grieskirchen), M-T Krauth(Medical University of Vienna), Leonhard Müllauer(Hochschule Campus Wien)
Leukemia
December 29, 2015
10.1038/leu.2015.360
Cited by 62

Related Papers

Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)
|Blood|2012|596
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
|Journal of Clinical Oncology|2011|540
Erythropoietin Treatment of Anemia Associated with Multiple Myeloma
|New England Journal of Medicine|1990|450
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients
|Blood|2011|448
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
|The Lancet Haematology|2020|351